Teva Pharmaceutical Industries TEVA
NYSE TEVA
$39.82 +0.94 (+2.42%)
As of: Sep 29, 2026 · 3:59 PM EDT

Teva Pharmaceutical Industries (TEVA) Common Equity (2009 - 2026)

Updated

Teva Pharmaceutical Industries (TEVA) reported Common Equity of $7.76 billion for Q2 2026, up 13.5% from $6.83 billion a year earlier but down 5.8% from the prior quarter.

Analysis

Teva Pharmaceutical Industries (TEVA) Common Equity (2009 - 2026) Analysis & Trends

At the end of FY2025, Teva Pharmaceutical Industries posted Common Equity of $7.91 billion, up 47.1% from FY2024.

  • Common Equity has a five-year compound annual growth rate of -6.5% (FY2020 to FY2025).
  • By year, Common Equity came in at $5.38 billion in FY2024 (-33.8%), $8.13 billion in FY2023 (-5.5%), $8.6 billion in FY2022 (-23.5%) and $11.24 billion in FY2021 (+1.7%).
  • Five-year quarterly Common Equity spans a low of $5.38 billion in Q4 2024 and a high of $11.45 billion in Q3 2021.
  • Year over year, Common Equity has now increased in each of the last five quarters, with growth averaging 5.7% over the last eight quarters.
  • The high point for year-over-year Common Equity in five years was Q4 2025 (growth of 47.1%); the low point was Q4 2024 (a decline of 33.8%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $8.23 billion (Q1 2026), $7.91 billion (Q4 2025) and $7.25 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 84.97 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -5.94 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 41.98 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 41.95 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 50.37 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 11.69 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 85.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 20.25 Bn
10 Teva Pharmaceutical Industries 45.31 Bn 32.16 Bn 2.15 Bn 7.76 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.76 Bn
Mar 31, 2026 8.23 Bn
Dec 31, 2025 7.91 Bn
Sep 30, 2025 7.25 Bn
Jun 30, 2025 6.83 Bn
Mar 31, 2025 6.27 Bn
Dec 31, 2024 5.38 Bn
Sep 30, 2024 6.38 Bn
Jun 30, 2024 6.56 Bn
Mar 31, 2024 7.54 Bn
Dec 31, 2023 8.13 Bn
Sep 30, 2023 7.39 Bn
Jun 30, 2023 7.59 Bn
Mar 31, 2023 8.50 Bn
Dec 31, 2022 8.60 Bn
Sep 30, 2022 9.51 Bn
Jun 30, 2022 9.81 Bn
Mar 31, 2022 10.26 Bn
Dec 31, 2021 11.24 Bn
Sep 30, 2021 11.45 Bn
API Access

Teva Pharmaceutical Industries Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=TEVA&period=max&api_key=YOUR_API_KEY